226 related articles for article (PubMed ID: 36311770)
21. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma.
Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C
J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457
[TBL] [Abstract][Full Text] [Related]
22. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
23. Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis.
Xie L; Wu S; He R; Li S; Lai X; Wang Z
Front Immunol; 2022; 13():901662. PubMed ID: 36059531
[TBL] [Abstract][Full Text] [Related]
24. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
[TBL] [Abstract][Full Text] [Related]
25. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
Tang YF; Qiao B; Huang YB; Wang M
Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
[No Abstract] [Full Text] [Related]
26. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
27. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment.
Wu D; Zhou Y; Shi X; Yi X; Sheng Z; Fan L; Ge J; Cheng W; Zhou W; He H; Fu D
Toxicol Appl Pharmacol; 2024 Jun; 487():116975. PubMed ID: 38762191
[TBL] [Abstract][Full Text] [Related]
28. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
29. The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer.
Wei Zhang ; Chen Y; Zeng Z; Peng Y; Li L; Hu N; Gao X; Cai W; Yin L; Xu Y; Zhang X; Tang D; Dai Y
Heliyon; 2022 Dec; 8(12):e12078. PubMed ID: 36619469
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
[TBL] [Abstract][Full Text] [Related]
31. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
[TBL] [Abstract][Full Text] [Related]
32. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
34. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
[TBL] [Abstract][Full Text] [Related]
35. An
Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
[TBL] [Abstract][Full Text] [Related]
37. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
38. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
Front Genet; 2022; 13():978840. PubMed ID: 36186442
[TBL] [Abstract][Full Text] [Related]
39. Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC).
Zhang Y; Lai H; Tang B
Dis Markers; 2021; 2021():4570235. PubMed ID: 34539936
[TBL] [Abstract][Full Text] [Related]
40. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]